Research programme: mannose receptor targeted monoclonal antibodies - Medarex
Alternative Names: Anti-mannose receptor monoclonal antibodies - MedarexLatest Information Update: 30 Sep 2009
At a glance
- Originator Medarex
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Sep 2009 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 24 Apr 2007 Preclinical development is ongoing
- 03 Dec 2003 Preclinical trials in Cancer in USA (unspecified route)